DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $226,000 | -46.1% | 11,235 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $419,000 | +0.7% | 11,235 | -31.0% | 0.00% | -33.3% |
| Q1 2021 | $416,000 | +77.0% | 16,283 | +52.9% | 0.00% | +50.0% |
| Q4 2020 | $235,000 | +55.6% | 10,648 | +27.1% | 0.00% | +100.0% |
| Q3 2020 | $151,000 | -32.0% | 8,378 | -4.1% | 0.00% | -66.7% |
| Q2 2020 | $222,000 | +65.7% | 8,739 | +19.7% | 0.00% | +50.0% |
| Q1 2020 | $134,000 | +9.8% | 7,303 | +26.9% | 0.00% | 0.0% |
| Q4 2019 | $122,000 | -31.1% | 5,756 | -53.4% | 0.00% | -33.3% |
| Q3 2019 | $177,000 | +12.7% | 12,340 | +23.8% | 0.00% | 0.0% |
| Q2 2019 | $157,000 | -7.6% | 9,966 | -14.2% | 0.00% | -25.0% |
| Q1 2019 | $170,000 | +46.6% | 11,618 | +8.9% | 0.00% | +33.3% |
| Q4 2018 | $116,000 | -27.5% | 10,673 | +1.6% | 0.00% | 0.0% |
| Q3 2018 | $160,000 | – | 10,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |